Experimental
C60 (Buckminsterfullerene)
The prediction game
Call it: rising or fading?
Where does C60 (Buckminsterfullerene) stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: E (thin evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 4.9/10
C60 (Buckminsterfullerene) shows modest antioxidant activity but the evidence does not support oral longevity claims for most users. The only reproducible human data come from a small cosmetic trial that found modest wrinkle reduction after topical application [Kato et al. 2010](https://pubmed.ncbi.nlm.nih.gov/21137794/), which does not translate to systemic benefits. Rodent studies that reported dramatic lifespan extension were limited to a single rat experiment and later corrected for figure errors [Baati et al. 2012](https://pubmed.ncbi.nlm.nih.gov/22498298/) and a subsequent corrigendum, while independent mouse work found no advantage over water controls and suggested possible harm when delivered in olive oil [Shytikov et al. 2021](https://pubmed.ncbi.nlm.nih.gov/33849306/). Accordingly, C60 (Buckminsterfullerene) may be of interest to highly controlled self-experiments focused on short-term recovery, but it carries uncertain efficacy and safety for broader longevity or performance use in general. ✅ Best for: High-stress endurance athletes, ultra-marathoners, and advanced self-experimenters who already have the basics handled, can afford therapeutic-grade C60 oil, can verify storage and quality controls, and accept that the human evidence base is functionally absent for oral longevity. The strongest fit is someone testing a short, measurable recovery block during unusually high training stress, with clear stop criteria and no fertility, pregnancy, medication, or cancer-treatment concerns. ❌ Avoid if: You are pregnant, planning pregnancy, breastfeeding, trying to conceive, pediatric, taking photosensitizing drugs, using anticancer therapy, using anticoagulants without clinician review, or unable to refrigerate and store C60 away from light. Avoid C60 if you want evidence-validated longevity interventions, are on a tight supplement budget, or would be using it before proven basics. The audit found no large human RCT, no meta-analysis, no Cochrane review, and no positive FDA efficacy signal for consumer health claims.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Experimental
- Trend
- Begins with Edition 2
- Momentum
- 0.2%
- BioHarmony Score
- 4.9/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.